SCHEMBL8366249

SCHEMBL8366249

CC(C)Oc1cccc(C(C(=O)N(C)CCCCOS(C)(=O)=O)c2ccc(Cl)c(Cl)c2)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.39
KDM4E B2RXH2 3/20 0.39
LMNA P02545 2/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
CYP3A4 P08684 2/20 0.35
MEN1 O00255 1/20 0.35
NPC1 O15118 1/20 0.35
CYP1A2 P05177 1/20 0.35
MAPT P10636 1/20 0.35
CYP2C9 P11712 1/20 0.35
CYP2C19 P33261 1/20 0.35
CASP3 P42574 1/20 0.35
HTT P42858 1/20 0.35
RAB9A P51151 1/20 0.35
KMT2A Q03164 1/20 0.35
SENP8 Q96LD8 1/20 0.35
SENP7 Q9BQF6 1/20 0.35
SENP6 Q9GZR1 1/20 0.35
ACHE P22303 2/20 0.34
FAAH O00519 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8364653 0.86 KDM4E (0.39) ALDH1A1KDM4ELMNASMN1; SMN2CYP3A4
SCHEMBL8365000 0.80 SLC6A3 (0.39) ALDH1A1KDM4ELMNASMN1; SMN2MEN1
SCHEMBL8315120 0.73 TACR2 (0.49) TACR1
SCHEMBL8970404 0.73 TACR1 (0.40) CYP3A4CYP1A2MAPTTACR1CYP2D6
SCHEMBL8368909 0.73 MEN1 (0.41) ALDH1A1KDM4ESMN1; SMN2MEN1KMT2A
SCHEMBL8126875 0.72 CCR5 (0.42) TACR1
SCHEMBL8370044 0.72 MEN1 (0.40) ALDH1A1KDM4ESMN1; SMN2MEN1KMT2A
SCHEMBL8565799 0.71 TACR1 (0.40) CYP3A4CYP1A2TACR1CYP2D6
SCHEMBL8592517 0.67 TACR1 (0.38) ALDH1A1LMNASMN1; SMN2MEN1NPC1
SCHEMBL8314053 0.66 TACR1 (0.37) SMN1; SMN2MEN1HTTKMT2ATACR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5939411-A PIPERIDINE DERIVATIVES SUBSTITUTED AT POSITION 4 WITH NEW FUNCTIONS OTHER THAN THOSE DESCRIBED PREVIOUSLY HAVE A HIGH AFFINITY FOR NEUROKININ RECEPTORS AND ARE USEFUL FOR TREATMENT OF SUBSTANCE P AND NEUROKININ DEPENDENT PATHOLOGIES SANOFI (FR) 1999-08-17 US disclosed
US-5830906-A Piperidine derivatives, process for obtaining them and pharmaceutical compositions containing them SANOFI (FR) 1998-11-03 US disclosed